Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Project #84: Microbial architects: How yeast cell wall components activate islet resident macrophages to drive beta-cell expansion

    Forecasted

    Project #84 supports Gabriella Cynthia Giese’s research on how yeast cell wall components activate islet macrophages to expand insulin-producing beta cells, exploring ways to prevent or treat type 1 diabetes.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Project #73: Gestation Drives Adaptive Dynamics in Beta Cell Metabolism, Function, and Heterogeneity

    This grant supports research into how pregnancy drives adaptive changes in beta cell metabolism and function, aiming to inform therapies for type 1 diabetes.

    DRCRolling submissions$75,000

    Project #79: Mechanisms of human ß-cell potentiation by non-glucose nutrients

    This grant supports research into how non-glucose nutrients, especially amino acids, boost human beta cell insulin secretion to advance type 1 diabetes therapies.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Project #86: Elucidation of the Regulatory Mechanisms of Naïve T Cells by Gut Microbial Metabolites for Therapeutic Strategies in T1D

    Project #86 supports Keiichiro Mine at Boston College in studying whether the gut microbial metabolite isoLCA can reduce inflammatory immune-cell activation to help prevent type 1 diabetes.

    DRCForecasted Jul 31, 2027$75,000Forecasted

    Project #85: BNIP3-Mediated Mitophagy Regulates ß-Cell Identity and Immunogenicity in T1D

    This grant supports research on how BNIP3-mediated mitophagy affects beta cell identity and immune response in type 1 diabetes, aiming to uncover new therapeutic approaches.

    DRCRolling submissions$75,000

    Project #76: Assessing spatial heterogeneity of the alpha cell dysfunction and testing its connection to the islet-specific T cells in T1D

    Project #76 supports Vira Kravets at UC San Diego in studying alpha cell dysfunction and immune targeting as possible triggers of type 1 diabetes, potentially informing prevention and treatment.

    DRCForecasted Jul 31, 2027$75,000Forecasted